Suchergebnisse - "Ling, Jiayu"

PubPharm (28)

1

Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer : The Randomized, Phase III OPTICAL Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Hu, H. | Zhang, J. | Li, Y. | +76

2

Efficacy and safety of ripretinib vs. sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib : A phase 2, multicenter, randomized, open-label study in China

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Li, J. | Zhang, J. | Zhang, Y. | +33

3

Capecitabine maintenance therapy in metastatic colorectal cancer patients with no evidence of disease : CAMCO trial

enthalten in: Future oncology (London, England) | 2023

von Ling, J. | Lin, Z. | Shi, L. | +8

4

Neoadjuvant Modified FOLFOXIRI With Selective Radiotherapy in Locally Advanced Rectal Cancer : Long-term Outcomes of Phase II Study and Propensity-Score-Matched Comparison With Chemoradiotherapy

enthalten in: Diseases of the colon and rectum | 2023

von Zhang, J. | Li, J. | Huang, M. | +6

5

Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer

enthalten in: Cancer cell | 2023

von Li, J. | Wu, C. | Hu, H. | +15

6

Neoadjuvant versus adjuvant imatinib in primary localized gastrointestinal stromal tumor

enthalten in: Journal of gastrointestinal oncology | 2023

von Ling, J. | Shi, L. | Cheng, X. | +8

7

Aprepitant plus palonosetron versus dexamethasone plus palonosetron in preventing chemotherapy-induced nausea and vomiting in patients with moderate-emetogenic chemotherapy : A randomized, open-label, phase 3 trial

enthalten in: EClinicalMedicine | 2022

von Cheng, Y. | Wu, Z. | Shi, L. | +9

8

mFOLFOXIRI versus mFOLFOX6 as neoadjuvant chemotherapy in locally advanced rectal cancer : A Propensity Score Matching Analysis

enthalten in: Clinical colorectal cancer | 2022

von Ding, M. | Zhang, J. | Hu, H. | +7

9

Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC) : a single-centre, parallel-group, non-comparative, randomised, phase 2 trial

enthalten in: The lancet. Gastroenterology & hepatology | 2022

von Hu, H. | Kang, L. | Zhang, J. | +27

CommentIn: Lancet Gastroenterol Hepatol. 2022 Jan;7(1):4-6. - PMID 34688372

10

mFOLFOXIRI with or without bevacizumab for conversion therapy of RAS/BRAF/PIK3CA mutant unresectable colorectal liver metastases : the FORBES non-randomized phase II trial

enthalten in: Annals of translational medicine | 2022

von Shen, C. | Hu, H. | Cai, Y. | +20

CommentIn: Ann Transl Med. 2022 Sep;10(18):952. - PMID 36267710